MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
28 06 2022
Historique:
received: 24 08 2021
accepted: 07 06 2022
entrez: 28 6 2022
pubmed: 29 6 2022
medline: 1 7 2022
Statut: epublish

Résumé

Neuroblastoma (NB) is a childhood cancer arising from sympatho-adrenal neural crest cells. MYCN amplification is found in half of high-risk NB patients; however, no available therapies directly target MYCN. Using multi-dimensional metabolic profiling in MYCN expression systems and primary patient tumors, we comprehensively characterized the metabolic landscape driven by MYCN in NB. MYCN amplification leads to glycerolipid accumulation by promoting fatty acid (FA) uptake and biosynthesis. We found that cells expressing amplified MYCN depend highly on FA uptake for survival. Mechanistically, MYCN directly upregulates FA transport protein 2 (FATP2), encoded by SLC27A2. Genetic depletion of SLC27A2 impairs NB survival, and pharmacological SLC27A2 inhibition selectively suppresses tumor growth, prolongs animal survival, and exerts synergistic anti-tumor effects when combined with conventional chemotherapies in multiple preclinical NB models. This study identifies FA uptake as a critical metabolic dependency for MYCN-amplified tumors. Inhibiting FA uptake is an effective approach for improving current treatment regimens.

Identifiants

pubmed: 35764645
doi: 10.1038/s41467-022-31331-2
pii: 10.1038/s41467-022-31331-2
pmc: PMC9240069
doi:

Substances chimiques

Fatty Acids 0
N-Myc Proto-Oncogene Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3728

Subventions

Organisme : NCI NIH HHS
ID : R01 CA224304
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA222224
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES030285
Pays : United States
Organisme : NIDCR NIH HHS
ID : U01 DE028233
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA220297
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES027725
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216426
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86
pubmed: 20113896
Cell Cycle. 2008 Aug;7(15):2392-400
pubmed: 18677108
Cell Metab. 2020 Aug 4;32(2):229-242.e8
pubmed: 32559414
Cell Rep. 2018 Sep 4;24(10):2596-2605.e5
pubmed: 30184495
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
EClinicalMedicine. 2021 Mar 30;34:100797
pubmed: 33870151
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Cell Death Dis. 2018 Feb 14;9(2):220
pubmed: 29445162
Nat Rev Cancer. 2007 Apr;7(4):281-94
pubmed: 17384583
Nature. 2019 May;569(7754):73-78
pubmed: 30996346
Anal Biochem. 2005 Jan 1;336(1):11-9
pubmed: 15582553
Am J Physiol Endocrinol Metab. 2013 Sep 15;305(6):E700-16
pubmed: 23880316
Nat Commun. 2021 Jun 28;12(1):4006
pubmed: 34183658
Cancer Res. 2021 Apr 1;81(7):1627-1632
pubmed: 33509943
J Exp Clin Cancer Res. 2019 Dec 19;38(1):498
pubmed: 31856871
Cancer Cell. 2016 Jan 11;29(1):104-116
pubmed: 26766592
Sci Transl Med. 2019 Feb 6;11(478):
pubmed: 30728288
J Biol Chem. 2000 Jul 21;275(29):21797-800
pubmed: 10823814
Nat Rev Cancer. 2016 Nov;16(11):732-749
pubmed: 27658529
Science. 1984 Jun 8;224(4653):1121-4
pubmed: 6719137
Cell Rep. 2019 Dec 10;29(11):3405-3420.e5
pubmed: 31825825
Prog Lipid Res. 2004 Mar;43(2):134-76
pubmed: 14654091
Cancer Res. 2019 Aug 1;79(15):3837-3850
pubmed: 31088832
Cancer Discov. 2015 Oct;5(10):1024-39
pubmed: 26382145
Cancer Res. 2004 Jun 1;64(11):3892-9
pubmed: 15172999
Medchemcomm. 2016 Apr 1;7(4):612-622
pubmed: 27446528
Curr Protoc Pharmacol. 2011 Mar;Chapter 14:Unit 14.17
pubmed: 21935903
Oncogene. 2004 Jan 22;23(3):753-62
pubmed: 14737110
Cancer Cell. 2015 Feb 9;27(2):271-85
pubmed: 25640402
Cancer Res. 2014 Feb 1;74(3):765-74
pubmed: 24335960
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50
pubmed: 18216770
Cancer Discov. 2018 Aug;8(8):1006-1025
pubmed: 29903879
J Clin Oncol. 1996 Feb;14(2):405-14
pubmed: 8636750
Mol Cell Biol. 2004 Jul;24(13):5923-36
pubmed: 15199147
Genes Dev. 2013 May 15;27(10):1115-31
pubmed: 23699409
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19190-5
pubmed: 23091029
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Cell Metab. 2018 Jun 05;27(6):1357
pubmed: 29874570
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10258-63
pubmed: 23733953
Cell Rep. 2014 Oct 9;9(1):349-365
pubmed: 25263561
Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76
pubmed: 18216772
Cancer Res. 2017 Oct 15;77(20):5503-5517
pubmed: 28811332
Cell Metab. 2019 Sep 3;30(3):556-572.e5
pubmed: 31447321
Mol Cell. 2010 Jul 30;39(2):171-83
pubmed: 20670887
Nature. 2015 Apr 9;520(7546):192-197
pubmed: 25830893
Cell Metab. 2020 Jan 7;31(1):62-76
pubmed: 31813823
Cancer Res. 2010 Feb 15;70(4):1377-88
pubmed: 20145147
Nat Commun. 2019 Nov 5;10(1):5026
pubmed: 31690716
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18782-7
pubmed: 19033189
iScience. 2021 Feb 01;24(2):102128
pubmed: 33659885
Sci Transl Med. 2019 Jan 30;11(477):
pubmed: 30700572
Cancer Discov. 2018 May;8(5):582-599
pubmed: 29510988
EMBO J. 1997 Jun 2;16(11):2985-95
pubmed: 9214616
Cancer Discov. 2020 Sep;10(9):1282-1295
pubmed: 32499221
Nature. 2017 Jan 5;541(7635):41-45
pubmed: 27974793
J Pathol. 2015 Jan;235(1):90-100
pubmed: 25142020
Sensors (Basel). 2019 Dec 20;20(1):
pubmed: 31861836
Biochim Biophys Acta. 2012 May;1821(5):852-7
pubmed: 21979150
PLoS One. 2008 Mar 12;3(3):e1798
pubmed: 18335064
Cell Death Dis. 2013 Apr 11;4:e586
pubmed: 23579273
iScience. 2019 Nov 22;21:188-204
pubmed: 31670074
Cancer Res. 2008 Dec 1;68(23):9735-45
pubmed: 19047152
Nat Med. 2016 Oct;22(10):1108-1119
pubmed: 27643638
Cancer Res. 2010 Dec 15;70(24):10351-61
pubmed: 20961996
Cell. 2006 Jul 14;126(1):107-20
pubmed: 16839880
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Clin Cancer Res. 2013 May 1;19(9):2368-80
pubmed: 23633458
Proc Natl Acad Sci U S A. 2013 May 28;110(22):8882-7
pubmed: 23671091
Nucleic Acids Res. 2003 Nov 1;31(21):6148-56
pubmed: 14576301

Auteurs

Ling Tao (L)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Mahmoud A Mohammad (MA)

Department of Pediatrics-Nutrition, Baylor College of Medicine, Houston, TX, 77030, USA.
Food Science and Nutrition Department, National Research Centre, El-Buhouth St., Dokki, Cairo, 12622, Egypt.

Giorgio Milazzo (G)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, 40126, Italy.

Myrthala Moreno-Smith (M)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Tajhal D Patel (TD)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.

Barry Zorman (B)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Andrew Badachhape (A)

Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030, USA.

Blanca E Hernandez (BE)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Amber B Wolf (AB)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Zihua Zeng (Z)

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

Jennifer H Foster (JH)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.

Sara Aloisi (S)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, 40126, Italy.

Pavel Sumazin (P)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Youli Zu (Y)

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA.

John Hicks (J)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, 77030, USA.

Ketan B Ghaghada (KB)

Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030, USA.

Nagireddy Putluri (N)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Advanced Technology Core, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.

Giovanni Perini (G)

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, 40126, Italy.

Cristian Coarfa (C)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.

Eveline Barbieri (E)

Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, 77030, USA. exbarbie@txch.org.
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA. exbarbie@txch.org.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH